Science Daily·3 min read·medium
Ozempic and Mounjaro linked to a surprising hair loss risk
✦AI Summary
A study published in The BMJ suggests a link between GLP-1 receptor agonists, such as Ozempic and Mounjaro, and a modest increase in the risk of hair loss. While the absolute risk remains low, researchers suggest that patients and clinicians should be aware of this potential side effect.
GLP-1 medications commonly used to manage type 2 diabetes and obesity may be associated with a modest increase in hair loss, according to a study published by The BMJ on July 22, 2026.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in